Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

57.70
Delayed Data
As of Nov 20
 -0.29 / -0.50%
Today’s Change
36.44
Today|||52-Week Range
58.23
+43.53%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 51.00, with a high estimate of 59.00 and a low estimate of 47.00. The median estimate represents a -11.61% decrease from the last price of 57.70.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in Haemonetics Corp. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.44
Sales
$227.8M
Reporting Date
Jan 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -8.33%
 
 
 
 
 
 
Growthannually 11.19%
 
 
 
 
 
 

Sales

Growthquarterly 1.08%
 
 
 
 
 
 
Growthannually 0.78%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.